Hemodialysis for cefepime intoxication: A case report


Ressource 1Télécharger: BIB_E4B72FAAFE84.P001.pdf (58.76 [Ko])
Etat: Public
Version: de l'auteur⸱e
ID Serval
Actes de conférence (partie): contribution originale à la littérature scientifique, publiée à l'occasion de conférences scientifiques, dans un ouvrage de compte-rendu (proceedings), ou dans l'édition spéciale d'un journal reconnu (conference proceedings).
Abstract (résumé de présentation): article court qui reprend les éléments essentiels présentés à l'occasion d'une conférence scientifique dans un poster ou lors d'une intervention orale.
Hemodialysis for cefepime intoxication: A case report
Titre de la conférence
11th Conference of the European Association for Clinical Pharmacology and Therapeutics
Mani L.Y., Kissling S., Burnier M., Buclin T., Renard D.
Geneva, Switzerland, August 28-31, 2013
Statut éditorial
Date de publication
Clinical Therapeutics
Introduction: We report a case of cefepime intoxication with acute
severe neurologic symptoms, which was treated by temporary hemodialysis.
Patients (or Materials) and Methods: Cefepime 2 g BID for endovascular
prosthesis infection was prescribed to a frail, chronically ill
88-year-old woman with a serum creatinine of 199 μmol/L and an
estimated creatinine clearance of 13 mL/min (Cockroft formula). Two
days later, she was transferred to a neurocritical care unit because
of acute aphasia, myoclonic jerks, and delirium with a Glasgow
coma scale score of 12/15. The following day, in the absence of
other causes, cefepime intoxication was hypothesized, and cefepime
was withdrawn after a total of 7 doses = 14 g. Over the next 24
hours, two 3-hour hemodialysis (HD) sessions were performed under
cefepime concentration monitoring.
Results: Cefepime plasma levels were measured by liquid chromatography/
mass spectrometry. There is no validated reference range,
but a study (Chapuis T et al, Critical Care, 2010) found a 50% risk
of neurotoxicity with residual levels > 15 mg/L. In our patient, levels
were 83.3 mg/L 10 hours after last dose, 24.1 mg/L immediately after
the first HD session, 13.4 mg/L immediately before the second HD
session, and 2.5 mg/L immediately after the second HD session. The
patient made a full clinical recovery over the next 48 hours. The 70%
to 80% fall in plasmatic levels observed during each HD session is
in accordance with literature data (Schmaldienst S et al, Eur J Clin
Pharmacol, 2000, and Manyor LM et al, Pharmacotherapy, 2008).
According to kinetic simulation, cefepime dropped at a concentration
< 15 mg/L 15 hours earlier with HD than it would have without.
Conclusion: Neuropsychiatric adverse effects of beta-lactam antibiotics
can be easily overlooked by clinicians. One should be especially
cautious with their use in very old and frail patients in whom plasma
creatinine poorly estimates renal function and cognitive impairment
is highly prevalent. Temporary hemodialysis effectively clears
cefepime, but its role in hastening clinical recovery may be limited.
Création de la notice
17/02/2014 13:45
Dernière modification de la notice
20/08/2019 16:08
Données d'usage